Unity Biotechnology, Inc.
Unity Biotechnology, Inc. (UBX) is a publicly traded company in the Unknown sector. Across all available filings, 14 corporate insiders have executed 114 transactions totaling $9.0M, demonstrating a bearish sentiment with -$9.0M in net insider flow. The most recent transaction on Aug 2, 2024 involved a sale of 139 shares valued at $213.
UBX Insider Activity Summary
Who Is Buying UBX Stock?
No significant insider buying has been recorded for UBX in the recent period.
Who Is Selling UBX Stock?
No significant insider selling has been recorded for UBX in the recent period.
Is Unity Biotechnology, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for UBX is bearish with an Insider Alignment Score of 0/100 and a net flow of -$9.0M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
UBX Frequently Asked Questions
Understanding UBX Insider Activity
Insider trading at Unity Biotechnology, Inc. (UBX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 14 insiders are actively trading UBX stock, having executed 114 transactions in the past 90 days. The most active insider is Nathaniel E. David (Executive), who has made 8 transactions totaling $9.0M.
Related Tools
Track Unity Biotechnology, Inc. Insider Activity
Get notified when executives and directors at UBX file new Form 4 transactions